Under the EFDA Directive, every pharmaceutical product manufactured in or imported into Ethiopia must carry a unique GS1 DataMatrix code encoding GTIN, serial number, batch number, and expiry date, with product movement data submitted to the EFDA national traceability platform to. Under the EFDA Directive, every pharmaceutical product manufactured in or imported into Ethiopia must carry a unique GS1 DataMatrix code encoding GTIN, serial number, batch number, and expiry date, with product movement data submitted to the EFDA national traceability platform to. EFDA-MVC provides a nationwide track and trace supply chain solution for pharmaceutical products sold within Ethiopia. ETHIOPIAN PHARMACEUTICAL The EFDA-MVC program is to provide a track and trace system that will ensure patient safety and security, and the integrity of the supply chain of medicine. As of August 19, 2025, Ethiopia is well on its way to transforming its pharmaceutical supply chain with the launch of its national traceability system. This initiative marks a significant leap. The Ethiopian Food and Drug Authority (EFDA), operating under the Food and Medicine Administration Proclamation No. 1112/2019, has issued a pharmaceutical traceability directive requiring track and trace on all medicines circulating in the Ethiopian market. 1263/2021 and its mandate defined under regulation No.